David Owens - 15 Sep 2022 Form 3 Insider Report for Nexalin Technology, Inc. (NXL)

Role: Chief Medical Officer, Director
Signature: /s/ David Owens Name: David Owens, M.D.
Issuer symbol: NXL
Transactions as of: 15 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Sep 2022, 17:03:05 UTC
Next filing: 20 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NXL	Common Stock						53,174	15 Sep 2022	Direct
holding	NXL	Common Stock						85,500	15 Sep 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

By LTB Investment Holdings LLC. Reporting Person has voting and dispositive control of the shares owned by LTB Investment Holdings LLC. Reporting Person has executed this Form 3 on behalf of himself and LTB Investment Holdings LLC